Construct: ORF ccsbBroadEn_14900
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF018900.1_s300c1, BRDN0000458196
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- Early stop codon detected
Originally Annotated References:
- Gene:
- DGKZ (8525)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
---|---|---|---|---|---|---|---|---|
1 | human | 8525 | DGKZ | diacylglycerol kinase zeta | NM_001199267.2 | 97.9% | 28.6% | (many diffs) |
2 | human | 8525 | DGKZ | diacylglycerol kinase zeta | NM_003646.4 | 97.8% | 28.6% | (many diffs) |
3 | human | 8525 | DGKZ | diacylglycerol kinase zeta | NM_001199266.2 | 97.2% | 28.4% | (many diffs) |
4 | human | 8525 | DGKZ | diacylglycerol kinase zeta | NM_001199268.2 | 95.3% | 26.1% | (many diffs) |
5 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_024448738.1 | 94.5% | 27.6% | (many diffs) |
6 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_024448737.1 | 94.4% | 27.6% | (many diffs) |
7 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_005253182.3 | 94.1% | 23.5% | (many diffs) |
8 | human | 8525 | DGKZ | diacylglycerol kinase zeta | NM_201533.3 | 94% | 23.4% | (many diffs) |
9 | human | 8525 | DGKZ | diacylglycerol kinase zeta | NM_201532.3 | 93.2% | 23.4% | (many diffs) |
10 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_024448736.1 | 91% | 22.7% | (many diffs) |
11 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_024448735.1 | 90.9% | 22.7% | (many diffs) |
12 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_024448734.1 | 90.1% | 22.6% | (many diffs) |
13 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_024448733.1 | 90% | 22.6% | (many diffs) |
14 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_024448739.1 | 88.6% | 20.4% | (many diffs) |
15 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_024448741.1 | 82% | 14.9% | (many diffs) |
16 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_024448740.1 | 81.7% | 22.6% | (many diffs) |
17 | human | 8525 | DGKZ | diacylglycerol kinase zeta | NM_001105540.2 | 80.2% | 19.9% | (many diffs) |
18 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_024448732.1 | 77.9% | 19.3% | (many diffs) |
19 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_017018456.1 | 77.4% | 22.5% | (many diffs) |
20 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_017018455.1 | 77.3% | 22.5% | (many diffs) |
21 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_024448730.1 | 75.3% | 21.9% | (many diffs) |
22 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_024448729.1 | 75.2% | 21.9% | (many diffs) |
23 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XM_024448731.1 | 73.3% | 20% | (many diffs) |
24 | human | 8525 | DGKZ | diacylglycerol kinase zeta | XR_002957206.1 | 61.4% | (many diffs) | |
25 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | NM_138306.2 | 86.8% | 27% | (many diffs) |
26 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XM_006498542.3 | 85.7% | 26.6% | (many diffs) |
27 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XM_006498543.2 | 83.9% | 22.1% | (many diffs) |
28 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XM_006498541.2 | 82.9% | 22.7% | (many diffs) |
29 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XM_006498540.2 | 82.8% | 21.8% | (many diffs) |
30 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XM_006498539.1 | 81.9% | 22.3% | (many diffs) |
31 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XM_017314875.1 | 74.3% | 14.8% | (many diffs) |
32 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XM_017314878.1 | 74.3% | 14.8% | (many diffs) |
33 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | NM_001166597.1 | 70.7% | 18.6% | (many diffs) |
34 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XM_017314867.1 | 70.6% | 18.6% | (many diffs) |
35 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XM_006498538.2 | 70% | 18.4% | (many diffs) |
36 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XM_006498537.1 | 69.9% | 18.4% | (many diffs) |
37 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XM_011239240.1 | 60.2% | 21.1% | (many diffs) |
38 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XM_011239241.2 | 41.3% | 28.4% | (many diffs) |
39 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XM_011239244.1 | 37.8% | 30.1% | (many diffs) |
40 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XR_374381.2 | 28.5% | (many diffs) | |
41 | mouse | 104418 | Dgkz | diacylglycerol kinase zeta | XR_866203.1 | 23.1% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 82
- ORF end:
- 907
- ORF length:
- 825
- Sequence:
-
1 CTGATAGTGA CCTGTTCGTT GCAACAAATT GATGAGCAAT GCTTTTTTAT AATGCCAACT 61 TTGTACAAAA AAGTTGGCAC CATGGAGCCG CGGGACGGTA GCCCCGAGGC CCGGAGCAGC 121 GACTCCGAGT CGGCTTCCGC CTCGTCCAGC GGCTCCGAGC GCGACGCCGG TCCCGAGCCG 181 GACAAGGCGC CGCGGCGACT CAACAAGCGG CGCTTCCCGG GGCTGCGGCT CTTCGGGCAC 241 AGGAAAGCCA TCACCAAGTC GGGCCTCCAG CACCTGGCCC CCCCTCCGCC CACCCCTGGG 301 GCCCCGTGCA GCGAGTCAGA GCGGCAGATC CGGAGTACAG TGGACTGGAG CGAGTCAGCG 361 ACATATGGGG AGCACATCTG GTTCGAGACC AACGTGTCCG GGGACTTCTG CTACGTTGGG 421 GAGCAGTACT GTGTAGCCAG GATGCTGAAG TCAGTGTCTC GAAGAAAGTG CGCAGCCTGC 481 AAGATTGTGG TGCACACGCC CTGCATCGAG CAGCTGGAGA AGATAAATTT CCGCTGTAAG 541 CCGTCCTTCC GTGAATCAGG CTCCAGGAAT GTCCGCGAGC CAACCTTTGT ACGGCACCAC 601 TGGGTACACA GACGACGCCA GGACGGCAAG TGTCGGCACT GTGGGAAGGG ATTCCAGCAG 661 AAGTTCACCT TCCACAGCAA GGAGATTGTG GCCATCAGCT GCTCGTGGTG CAAGCAGGCA 721 TACCACAGCA AGGTGTCCTG CTTCATGCTG CAGCAGATCG AGGAGCCGTG CTCGCTGGGG 781 GTCCACGCAG CCGTGGTCAT CCCGCCCACC TGGATCCTCC GCGCCCGGAG GCCCCAGAAT 841 ACTCTGAAAG CAAGCAAGAA GAAGAAGAGG GCATCCTTTC AAGAGGaagt ccagcaagaa 901 agggcctgag gagggccgct ggagaccctt catcatcagg cccaccccct ccccgctcat 961 gaagcccctg ctggtgtttg tgaaccccaa gagtgggggc aaccagggtg caaagatcat 1021 ccagtctttc ctctggtatc tcaatccccg acaagtcttc gacctgagcc agggagggcc 1081 caaggaggcg ctggagatgt accgcaaagt gcacaacctg cggatcctgg cgtgcggggg 1141 cgacggcacg gtgggctgga tcctctccac cctggaccag ctacgcctga agccgccacc 1201 ccctgttgcc atcctgcccc tgggtactgg caacgacttg gcccgaaccc tcaactgggg 1261 tgggggctac acagatgagc ctgtgtccaa gatcctctcc cacgtggagg aggggaacgt 1321 ggtacagctg gaccgctggg acctccacgc tgagcccaac cccgaggcag ggcctgagga 1381 ccgagatgaa ggcgccaccg accggttgcc cctggatgtc ttcaacaact acttcagcct 1441 gggctttgac gcccacgtca ccctggagtt ccacgagtct cgagaggcca acccagagaa 1501 attcaacagc cgctttcgga ataagatgtt ctacgccggg acagctttct ctgacttcct 1561 gatgggcagc tccaaggacc tggccaagca catccgagtg gtgtgtgatg gaatggactt 1621 gactcccaag atccaggacc tgaaacccaa gtgtgttgtt ttcctgaaca tccccaggta 1681 ctgtgcgggc accatgccct ggggccaccc tggggagcac cacgactttg agccccagcg 1741 gcatgacgac ggctacctcg aggtcattgg cttcaccatg acgtcgttgg ccgcgctgca 1801 ggtgggcgga cacggcgagc ggctgacgca gtgtcgcgag gtggtgctca ccacatccaa 1861 ggccatcccg gtgcaggtgg atggcgagcc ctgcaagctt gcagcctcac gcatccgcat 1921 cgccctgcgc aaccaggcca ccatggtgca gaaggccaag cggcggagcg ccgcccccct 1981 gcacagcgac cagcagccgg tgccagagca gttgcgcatc caggtgagtc gcgtcagcat 2041 gcacgactat gaggccctgc CTTACGACAA GGGAGCAATT AAAGGGAGGC CTTTTTCCCG 2101 CTGGGCAATG TTGTGGTTCC AGGGAGACAT GACCTTAGAA CTTTGCCCGG GCCCACATGA 2161 AGAGATTCCA ACAGGAGCCC CGATGTGCGG GAGGCCAAGT CCCGAACATG CCAGAAATGT 2221 CCCCCAAGTG GTGTTTCCTG GACGCCACCA CTGCCAGCCG TTTCTACAGG ATCGACCGAG 2281 CCCAGGAGCA CCTCAACTAT GTGACTGAGA TCGCACCGGC CTGAGGTTGN TTTCCNGGCC 2341 CCCGNGCNGC NGGGGGCTTC GGCCCCNCCC NNACCTCCCA CCCCCCCACC TTCCCCTCTC 2401 CCCACCTCAC CCTGCTCACC CACGCCCCGG TCACTGCAAG GGGATGCTGC ACCCCCTCAA 2461 GGTGAAGAGC TGATTGAGGC TGCCAAGAGG AACGACTTCT GTAAGCTCCA GGAGCTGCAC 2521 CGAGCTGGGG GCGACCTCAT GCACCGAGAC GAGCAGAGTC GCACGCTCCT GCACCACGCA 2581 GTCAGCACTG GCAGCAAGGA TGTGGTCCGC TACCTGCTGG ACCACGCCCC CCCAGAGATC 2641 CTTGATGCGG TGGAGGAAAA CGGGGAGACC TGTTTGCACC AAGCAGCGGC CCTGGGCCAG 2701 CGCACCATCT GCCACTACAT CGTGGAGGCC GGGGCCTCGC TCATGAAGAC AGACCAGCAG 2761 GGCGACACTC CCCGGCAGCG GGCTGAGAAG GCTCAGGACA CCGAGCTGGC CGCCTACCTG 2821 GAGAACCGGC AGCACTACCA GATGATCCAG CGGGAGGACC AGGAGACGGC TGTGTTGCCA 2881 ACTTTCTTGT ACAAAGTTGG CATTATAAGA AAGCATTGCT TATCAATTTG TTGCAACGAA 2941 CAGGTCACTA TCAGTCAAAA TAAAATCATT ATTGCCATCC CAGCTGATAT T